Realization of part of clinical trial called: A randomized, double-blind, multicenter clinical trial comparing the effects of treatment with ticagrelor compared to treatment with aspirin for the prevention of major vascular events in patients with acute ischemic stroke or transient ischemic attack ( TIA )